David S. Allan

Psychiatry

4185 St George Rd
Williston, VT 05495

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 167 publications

Effect of Stem Cell Cryopreservation on Day 60 Donor Chimerism in Unrelated Donor Allogeneic Stem Cell Transplantation using Reduced Intensity Conditioning and ATG-based GVHD Prophylaxis.

Effect of Stem Cell Cryopreservation on Day 60 Donor Chimerism in Unrelated Donor Allogeneic Stem Cell Transplantation using Reduced Intensity Conditioning and ATG-based GVHD Prophylaxis.

Journal: Transplantation and cellular therapy

Published: August 06, 2026

Changes in unrelated donor usage for allogeneic hematopoietic cell transplant in Canada: 2013-2023 and identifying priorities in donor selection.

Changes in unrelated donor usage for allogeneic hematopoietic cell transplant in Canada: 2013-2023 and identifying priorities in donor selection.

Journal: Transfusion

Published: March 18, 2026

A scoping review of gene editing in clinical trials: identifying aspects of trial design to accelerate clinical adoption.

A scoping review of gene editing in clinical trials: identifying aspects of trial design to accelerate clinical adoption.

Journal: Cytotherapy

Published: February 11, 2026

Defining the Limits of Pre-Transplant Risk Prediction in AML: Evidence From Machine Learning and Regression Models.

Defining the Limits of Pre-Transplant Risk Prediction in AML: Evidence From Machine Learning and Regression Models.

Journal: Transplantation and cellular therapy

Published: October 28, 2025

Genetic Findings of Potential Donor Origin in Cells Used for Cell and Gene Therapy: Recommendations from the World Marrow Donor Association.

Genetic Findings of Potential Donor Origin in Cells Used for Cell and Gene Therapy: Recommendations from the World Marrow Donor Association.

Journal: Transplantation and cellular therapy

Published: September 03, 2025

Factors Associated With Prolonged Inpatient Stay in Patients Undergoing Outpatient Allogeneic Stem Cell Transplantation.

Factors Associated With Prolonged Inpatient Stay in Patients Undergoing Outpatient Allogeneic Stem Cell Transplantation.

Journal: Transplantation and cellular therapy

Published: September 02, 2025

Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias.

Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias.

Journal: Blood advances

Published: August 18, 2025

A systematic review of published clinical studies using cell-derived extracellular vesicles: A focus on efficacy in COVID-19 and wound healing.

A systematic review of published clinical studies using cell-derived extracellular vesicles: A focus on efficacy in COVID-19 and wound healing.

Journal: Current research in translational medicine

Published: July 11, 2025

Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular Therapy.

Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular Therapy.

Journal: Transplantation and cellular therapy

Published: July 10, 2025

Real-World Selection of Patients for Allogeneic HCT at a Single Centre: Lack of a Suitable Donor and Other Reasons for Not Proceeding.

Real-World Selection of Patients for Allogeneic HCT at a Single Centre: Lack of a Suitable Donor and Other Reasons for Not Proceeding.

Journal: Current oncology (Toronto, Ont.)

Published: July 08, 2025

The emerging promise of induced pluripotent stem cells in clinical studies: a systematic scoping review of the literature and registered clinical trials.

The emerging promise of induced pluripotent stem cells in clinical studies: a systematic scoping review of the literature and registered clinical trials.

Journal: Cytotherapy

Published: April 22, 2025

An updated meta-analysis of umbilical cord blood to treat cerebral palsy: distinguishing cord blood infusions from mesenchymal stromal cell therapy.

An updated meta-analysis of umbilical cord blood to treat cerebral palsy: distinguishing cord blood infusions from mesenchymal stromal cell therapy.

Journal: Current research in translational medicine

Published: April 08, 2025

Showing 1-12 of 167

Last Updated: 09/26/2026